Your browser doesn't support javascript.
loading
High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers.
Miyamoto, M; Takano, M; Iwaya, K; Shinomiya, N; Goto, T; Kato, M; Suzuki, A; Aoyama, T; Hirata, J; Nagaoka, I; Tsuda, H; Furuya, K.
Affiliation
  • Miyamoto M; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Saitama 359-8513, Japan.
  • Takano M; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Saitama 359-8513, Japan.
  • Iwaya K; Department of Basic Pathology, National Defense Medical College Hospital, Tokorozawa, Saitama 359-8513, Japan.
  • Shinomiya N; Department of Molecular Biology, National Defense Medical College Hospital, Tokorozawa, Saitama 359-8513, Japan.
  • Goto T; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Saitama 359-8513, Japan.
  • Kato M; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Saitama 359-8513, Japan.
  • Suzuki A; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Saitama 359-8513, Japan.
  • Aoyama T; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Saitama 359-8513, Japan.
  • Hirata J; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Saitama 359-8513, Japan.
  • Nagaoka I; Department of Host Defense and Biochemical Research, Juntendo University Graduate School of Medicine, Tokyo 113-8431, Japan.
  • Tsuda H; Department of Basic Pathology, National Defense Medical College Hospital, Tokorozawa, Saitama 359-8513, Japan.
  • Furuya K; Department of Obstetrics and Gynecology, National Defense Medical College Hospital, Tokorozawa, Saitama 359-8513, Japan.
Br J Cancer ; 112(4): 739-44, 2015 Feb 17.
Article in En | MEDLINE | ID: mdl-25628093

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Serine Endopeptidases / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Cystadenocarcinoma, Serous / Mitochondrial Proteins Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Year: 2015 Type: Article

Full text: 1 Database: MEDLINE Main subject: Ovarian Neoplasms / Serine Endopeptidases / Antineoplastic Combined Chemotherapy Protocols / Biomarkers, Tumor / Cystadenocarcinoma, Serous / Mitochondrial Proteins Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Year: 2015 Type: Article